Fortress Biotech
FBIO
#9469
Rank
HK$0.92 B
Marketcap
HK$27.83
Share price
0.57%
Change (1 day)
80.00%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): HK$1.04 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are HK$66.16 Million. In 2025 the company made an earning of -HK$0.27 Billion, an increase over its 2024 earnings that were of -HK$0.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$1.04 B-495.22%
2025 -HK$0.27 Billion-72.02%
2024 -HK$0.95 Billion-21.6%
2023 -HK$1.21 Billion-28.03%
2022 -HK$1.68 Billion29.88%
2021 -HK$1.29 Billion59.8%
2020 -HK$0.81 Billion1.17%
2019 -HK$0.8 Billion-19.84%
2018 -HK$1 Billion28.99%
2017 -HK$0.78 Billion37.92%
2016 -HK$0.56 Billion32.31%
2015 -HK$0.43 Billion164.31%
2014 -HK$0.16 Billion-45.14%
2013 -HK$0.3 Billion37.55%
2012 -HK$0.22 Billion-22.91%
2011 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
HK$0.71 B-31.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.93 Billion-188.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-HK$0.27 Billion-125.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-HK$0.27 Billion-125.43%๐Ÿ‡บ๐Ÿ‡ธ USA